Literature DB >> 22479054

Stability of pantoprazole sodium in glass vials, polyvinyl chloride minibags, and polypropylene syringes.

Ronald F Donnelly1.   

Abstract

BACKGROUND: Pantoprazole sodium, a proton-pump inhibitor, is approved for the short-term treatment of several types of ulcer, Zollinger-Ellison syndrome, and gastroesophageal reflux disease.
OBJECTIVE: To determine the physical compatibility and chemical stability of ethylenediaminetetra-acetic acid (EDTA)-free pantoprazole in glass vials, polypropylene syringes, and polyvinylchloride (PVC) minibags, after storage at 2°C to 8°C with protection from light or at 20°C to 25°C with exposure to light.
METHODS: Solutions of pantoprazole 4 mg/mL reconstituted in 0.9% sodium chloride (normal saline [NS]) were stored in glass vials at 20°C to 25°C. Similar solutions were transferred to polypropylene syringes and stored at 2°C to 8°C. Stock solution was further diluted, in 5% dextrose in water (D5W) or NS, to 0.4 or 0.8 mg/mL, and samples were then packaged in PVC minibags for storage at 2°C to 8°C or at 20°C to 25°C. Samples collected on days 0, 2, 3, 7, 14, 21, and 28 were analyzed in duplicate with a stability-indicating high-performance liquid chromatography assay.
RESULTS: Pantoprazole 4 mg/mL was stable (i.e., retained at least 90% of initial concentration) for 3 days when stored in glass vials at 20°C to 25°C or for 28 days when stored in polypropylene syringes at 2°C to 8°C. Pantoprazole 0.4 mg/mL diluted in D5W and stored in PVC minibags was stable for 2 days at 20°C to 25°C or for 14 days at 2°C to 8°C. At 0.8 mg/mL, pantoprazole in D5W was stable for 3 days at 20°C to 25°C or 28 days at 2°C to 8°C. Pantoprazole diluted to either 0.4 or 0.8 mg/mL in NS and stored in PVC minibags was stable for 3 days at 20°C to 25°C or 28 days at 2°C to 8°C.
CONCLUSIONS: The present study confirmed or extended previously reported expiry dates for pantoprazole sodium packaged in glass vials, polypropylene syringes, and PVC minibags.

Entities:  

Year:  2011        PMID: 22479054      PMCID: PMC3130754          DOI: 10.4212/cjhp.v64i3.1022

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN: 0008-4123


  2 in total

1.  Stability of pantoprazole in 0.9% sodium chloride injection in polypropylene syringes.

Authors:  Cary E Johnson
Journal:  Am J Health Syst Pharm       Date:  2005-11-15       Impact factor: 2.637

2.  Extended stability of pantoprazole for injection in 0.9% sodium chloride or 5% dextrose at 4°c and 23°c.

Authors:  Scott Walker; John Iazzetta; Shirley Law
Journal:  Can J Hosp Pharm       Date:  2009-03
  2 in total
  2 in total

1.  Vincamine Modulates the Effect of Pantoprazole in Renal Ischemia/Reperfusion Injury by Attenuating MAPK and Apoptosis Signaling Pathways.

Authors:  Michael A Fawzy; Sherif A Maher; Mahmoud A El-Rehany; Nermeen N Welson; Nisreen K A Albezrah; Gaber El-Saber Batiha; Moustafa Fathy
Journal:  Molecules       Date:  2022-02-18       Impact factor: 4.411

2.  Re-evaluating the Inhibition of Stress Erosions (REVISE): a protocol for pilot randomized controlled trial.

Authors:  Waleed Alhazzani; Gordon Guyatt; John C Marshall; Richard Hall; John Muscedere; Francois Lauzier; Lehana Thabane; Mohammed Alshahrani; Shane W English; Yaseen M Arabi; Adam M Deane; Tim Karachi; Bram Rochwerg; Simon Finfer; Nick Daneman; Nicole Zytaruk; Diane Heel-Ansdell; Deborah Cook; On Behalf Of
Journal:  Ann Saudi Med       Date:  2016 Nov-Dec       Impact factor: 1.526

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.